Morgan Stanley analyst Meta Marshall lowered the firm’s price target on Nutanix (NTNX) to $82 from $90 and keeps an Overweight rating on the shares. A Q1 revenue miss and lowered FY26 top-line outlook are “messy,” but largely reflect revenue recognition timing, the analyst tells investors. With NNARR growth accelerating, the firm’s thesis remains intact, but the firm lowers its price target on lower revenue visibility, the analyst added.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTNX:
- Nutanix price target lowered to $72 from $88 at Piper Sandler
- Nutanix: Strong Fundamentals and Financial Resilience Justify Buy Rating Despite Revenue Timing Challenges
- Nutanix price target lowered to $65 from $95 at KeyBanc
- Nutanix price target lowered to $57 from $71 at Wells Fargo
- Nutanix price target lowered to $75 from $93 at BofA